EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis

Aoise O'Neill, Norashikin Zakaria, Courtney Bull, Hannah Egan, Shania M Corry, Niamh A Leonard, Clodagh O'Meara, Linda Howard, Anastasija Walsh, Eileen Reidy, Jenny Che, Li Peng und 12 weitere

Journal for ImmunoTherapy of Cancer · 2025-10 · 13 (10) · e012491

DOI: 10.1136/jitc-2025-012491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 19.10.2025. Verfasst von Aoise O'Neill und 23 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Pharmacology and Therapeutics, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Irel…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Immunity, Innate, Sialic Acid Binding Immunoglobulin-like Lectins, Stromal Cells. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health Research Charities Ireland -Health Research Board, Irish Cancer Society, Science Foundation Ireland and the Engineering and Physical Sciences Research Council Centre for Doctoral Training in Engineered Tissues for Discovery, Industr….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The immunosuppressive tumor microenvironment reduces immune response effectiveness in stromal-rich tumors, including consensus molecular subtype 4 colorectal cancer (CRC). Mesenchymal stromal cells (MSCs), precursors to cancer-associated fibroblasts (CAFs), promote cancer progression by suppressing anti-tumor immune responses. Hypersialylation of glycans on tumors engages Siglec receptors on immune cells, driving immune dysfunction, but its role in stromal-mediated suppression of innate immunity remains unclear.

Methods

Sialylation, Sialic acids and Siglec ligands were measured on CRC tissue, primary human normal-associated fibroblasts (NAFs), CAFs, and tumor-conditioned MSCs (MSC TCS ) using transcriptional profiles, immunohistochemistry and flow cytometry, respectively. The effect of stromal cell sialylation on macrophages and NK cells was assessed in ex vivo human primary stromal and immune cell co-cultures, and expression of Siglec-10 and immune cell phenotype markers and function was measured by flow cytometry and real-time imaging. Using an immunocompetent Balb/c CT26 mouse model, we induced tumors with/without conditioned stromal cells, with/without pretreatment of stromal cells with sialyltransferase inhibitor (3FAX) or sialidase (E610). We assessed the effect of stromal cell sialylation on macrophages and NK cells in the tumor and secondary lymphoid tissues by flow cytometry.

Results

Stromal cells, including CAFs, in CRC tumors are highly sialylated compared with epithelial cancer cells and are associated with high expression of the sialyltransferase ST6GALNAC6 . Genetic knockdown of ST6GALNAC6 reduced the expression of stromal cell Siglec-10 ligands in MSCs. CAFs and MSC TCS induced Siglec-10 on macrophages and NK cells and impaired macrophage phagocytosis and NK cell cytotoxicity. Sialidase treatment reduced Siglec-10 expression, restoring macrophage and NK cell antitumor functions. In vivo and ex vivo , desialylation of stromal cells increased macrophage activation (CD11b + CD80 + ) and reduced immunosuppressive marker expression (CD206, PD-L1, Siglec-G) in lymphoid tissues, indicating sustained systemic anti-tumor immunity. Intratumoral NK cells exhibited high Siglec-G expression and impaired cytotoxicity, and granzyme B expression significantly increased with sialidase treatment of stromal cells. In an inflammatory tumor model, inflammatory tumor-conditioned MSCs (MSC iTCS ) promoted metastasis and Siglec-G induction on NK cells and macrophages, both reversed by sialyltransferase inhibition, underscoring the effects of stromal modulation of innate immune cell function in inflammatory tumors.

Conclusions

Stromal cell sialylation modulates innate immune suppression in CRC via the sialic acid/Siglec axis. Targeting stromal sialylation restores NK cytotoxicity and macrophage activation, offering novel insights that may shape therapeutic strategies for reversing immunosuppression in stromal-rich tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsImmunity, InnateSialic Acid Binding Immunoglobulin-like LectinsStromal CellsMesenchymal Stem CellsN-Acetylneuraminic AcidAnimalsHumansMiceTumor MicroenvironmentPhenotypeMice, Inbred BALB CMacrophagesFemale

Stichwörter der Autor:innen

Colon CancerImmune modulatoryImmunosuppressionSialic acid/Siglec axisStromaTumor microenvironment - TME

Substanzen

Sialic Acid Binding Immunoglobulin-like LectinsN-Acetylneuraminic Acid

Autor:innen und Institutionen

  • Discipline of Pharmacology and Therapeutics, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland.
  • Regenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine Nursing and Health Sciences, University of Galway, Galway, Ireland.
  • Lambe Institute for Translational Research, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland.
  • Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Centre for Human Genetics, University of Oxford, Oxford, UK.
  • CÚRAM Centre for Research in Medical Devices, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland.

Förderung

  • Health Research Charities Ireland -Health Research Board
  • Irish Cancer Society
  • Science Foundation Ireland and the Engineering and Physical Sciences Research Council Centre for Doctoral Training in Engineered Tissues for Discovery, Industr…
  • Research Ireland

Zitieren

APA

O'Neill, A., Zakaria, N., Bull, C., Egan, H., Corry, S. M., Leonard, N. A., O'Meara, C., Howard, L., Walsh, A., Reidy, E., Che, J., Peng, L., Cao, L., Egan, L. J., Ritter, T., Sheehan, M., Canney, A., Culligan, K., Hogan, A. M., …, & Ryan, A. E. (2025). Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis. Journal for ImmunoTherapy of Cancer, 13(10), e012491. https://doi.org/10.1136/jitc-2025-012491

Vancouver

O'Neill A, Zakaria N, Bull C, Egan H, Corry SM, Leonard NA, et al. Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis. Journal for ImmunoTherapy of Cancer. 2025;13(10):e012491. doi:10.1136/jitc-2025-012491

BibTeX
@article{ONeill2025,
  author = {O'Neill, Aoise and Zakaria, Norashikin and Bull, Courtney and Egan, Hannah and Corry, Shania M and Leonard, Niamh A and O'Meara, Clodagh and Howard, Linda and Walsh, Anastasija and Reidy, Eileen and Che, Jenny and Peng, Li and Cao, Lizhi and Egan, Laurence J and Ritter, Thomas and Sheehan, Margaret and Canney, Aoife and Culligan, Kevin and Hogan, Aisling M and Hynes, Sean O and Dunne, Philip D and O'Dwyer, Michael and Treacy, Oliver and Ryan, Aideen E},
  title = {Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  volume = {13},
  number = {10},
  pages = {e012491},
  doi = {10.1136/jitc-2025-012491}
}
Kostenlos starten →